|
PART
|
96T
|
48T
|
STORAGE
|
|
Pre-Coated Plate
|
8×12
|
8×6
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Standards
|
2 vials
|
1 vial
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Biotinylated Antibody (1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Conjugate(1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Antibody Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Standard Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Sample Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Washing Buffer (1:25)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent A
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent B
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent C
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Manual
|
1 set
|
1 set
|
RT
|
Place collected whole blood in refrigerator at 4 ℃ overnight. Then centrifuge for 10mins at 1000-3000 rpm. Take supernatant and either test immediately or place samples at -20 ℃/-80 ℃(1-3 months) for storage.
Take plasma where EDTA, sodium citrate, or heparin has been added as anticoagulant. Mix well. Centrifuge mixture for 10mins at 1000-3000 rpm. Take supernatant and test immediately or place samples at -20 ℃ /-80 ℃ (1-3 months) for storage.
Take tissue slices which have been washed in 0.01 M PBS and then a tissue protein extraction reagent has been added according to proportion of 1 g to 5-10 mL and then mixed on ice bath. After sufficient homogenization, please then centrifuge for 10mins at 5000-10000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10 mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
|
TYPICAL DATA
|
Reference STD1
|
Reference STD2
|
Reference STD3
|
Reference STD4
|
Reference STD5
|
Reference STD6
|
Reference STD7
|
Reference STD8
|
|
RPA1, ng/mL
|
10
|
5
|
2.5
|
1.25
|
0.625
|
0.313
|
0.156
|
0
|
|
RPA1, OD.
|
2.931
|
1.628
|
0.905
|
0.503
|
0.279
|
0.155
|
0.086
|
0.057
|
|
SEPT9, ng/mL
|
5
|
2.5
|
1.25
|
0.625
|
0.313
|
0.156
|
0.078
|
0
|
|
SEPT9, OD.
|
3.272
|
1.818
|
1.01
|
0.561
|
0.312
|
0.173
|
0.096
|
0.064
|
|
SGOL1, ng/mL
|
10
|
5
|
2.5
|
1.25
|
0.625
|
0.313
|
0.156
|
0
|
|
SGOL1, OD.
|
3.602
|
2.001
|
1.112
|
0.618
|
0.343
|
0.191
|
0.106
|
0.071
|
|
SUMO3, ng/mL
|
10
|
5
|
2.5
|
1.25
|
0.625
|
0.313
|
0.156
|
0
|
|
SUMO3, OD.
|
2.584
|
1.436
|
0.798
|
0.443
|
0.246
|
0.137
|
0.076
|
0.051
|
STANDARD CURVE
To assess linearity of the assay, samples were spiked with high concentrations of Human RPA1, SEPT9, SGOL1, SUMO3 and diluted with the appropriate calibrator diluent to produce samples with values within the dynamic range of the assay.
|
Matrix
|
Scope %
|
Average % Recovery Rate
|
|
serum(n=5)
|
85-93
|
89
|
|
EDTA plasma(n=5)
|
86-103
|
94.5
|
|
Cell Culture Media(n=5)
|
95-99
|
97
|
|
Within-Run Precision
|
Inter-Batch Precision
|
|||||
|
Sample
|
1
|
2
|
3
|
1
|
2
|
3
|
|
n
|
20
|
20
|
20
|
20
|
20
|
20
|
|
CV%
|
6.1
|
6
|
6.3
|
7.5
|
8.7
|
8
|